Treatment Optimization of the Dyslipidemia in Type 2 Diabetes

dc.contributor.author	Akramkhuzhaeva A.B
dc.contributor.author	Satibaldiyeva N.R
dc.date.accessioned	2026-01-02T11:33:03Z
dc.date.issued	2023-05-28
dc.description.abstract	This article studies the data on evaluation of the efficacy and safety of the drug Rozulip plus 10/10 mg in patients with type 2 diabetes mellitus with diabetic dyslipidemia. In addition, the research and basic results are given with numbers. The safety of examination was assessed by the number and type of registered adverse side effects, as well as by the detection of clinically significant changes in blood biochemical parameters.
dc.format	application/pdf
dc.identifier.uri	https://geniusjournals.org/index.php/emrp/article/view/4322
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/77614
dc.language.iso	eng
dc.publisher	Genius Journals
dc.relation	https://geniusjournals.org/index.php/emrp/article/view/4322/3671
dc.source	Eurasian Medical Research Periodical; Vol. 20 (2023): EMRP; 222-227
dc.source	2795-7624
dc.subject	dyslipidemia
dc.subject	diabetes
dc.title	Treatment Optimization of the Dyslipidemia in Type 2 Diabetes
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: ab_2023_treatment_optimization_of_the_dyslipidem.pdf
item.page.filesection.size: 249.56 KB
item.page.filesection.format: Adobe Portable Document Format